Medication List in and Out of Hospital

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by University of Oslo.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
University of Oslo
ClinicalTrials.gov Identifier:
NCT01288846
First received: February 2, 2011
Last updated: February 3, 2011
Last verified: January 2011
  Purpose

30 patients acute hospitalized to medical ward and their medication records are examined. It is to be recorded how the investigators find information about medicine use by the reception when they do not follow the patient. The record of the changes made during hospital stay is examined, whether they are justified in the discharge summaries and whether they are described in the medical list. After a month is to find out if the GP has recorded or possibly rejected changes to medication made in hospital.


Condition
Febrile Illness
Acute Cardiovascular Disease
Acute Respiratory Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Communication About Medication Through the Medication List Coming Into the Hospital With the Patient, Being Changed in the Hospital and Then Returning With the Patient to the Community.

Further study details as provided by University of Oslo:

Primary Outcome Measures:
  • Changes in medication [ Time Frame: after 2 months ] [ Designated as safety issue: No ]
    It is studied when the patient is still in hospital an 1 month after he is at home.


Estimated Enrollment: 30
Study Start Date: March 2011
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Acutly ill, Medical ward, consent
group of acutely ill patient who uses three or more drugs, must be able to give consent.

Detailed Description:

Furthermore is to be recorded how the investigators find information about medicine use by the reception when they do not follow the patient and how long it takes to find the right medicine list. The record of the changes made during hospital stay is examined, whether they are justified in the discharge summaries and whether they are described in the medical list. After a month is to find out if the GP has recorded or possibly rejected changes to medication made in hospital.

This shall be recorded in the review of 30 patient with a focus on their medication list and follow them from admission to a month after discharge.

Medicine List in discharge summaries will be compared with medication written in journal during hospital stay and changes described in the text summaries and medication lists should be checked against the same journal.

Medicine list in the municipality one month after discharge shall be compared with discharge summaries and it will be mapped on the GP register, modified and considered if they are valid.

Hypothesis:

Medicine list is missing at admission by > 50% of patients admitted acutely into hospital.

Medicine List at admission, when available, is often incomplete. When the medication list is not available at admission, its content is often incomplete even after the staff at reception have tried to gather information from different sources.

Changes of regular medication is not always present in the discharge summaries. The changes are not always justified in the discharge summaries. The GP often do not correct the medication list in the journal to the discharge summary.

The GP does not give the patient an updated printout of the list at the first medical consultation after admission.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Acutely hospitalized patients into medical ward

Criteria

Inclusion Criteria:

  • acute hospitalized to medical ward
  • using three or more drugs, prescription only

Exclusion Criteria:

  • not been able to give consent, if too severely ill or not mentally capable
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01288846

Contacts
Contact: Karin Frydenberg, GP +4790863737 frydrein@online.no
Contact: Mette Brekke, Professor +4792832865 mette.brekke@medisin.uio.no

Locations
Norway
Sykehuset Innlandet HF Gjøvik Not yet recruiting
Gjøvik, Norway, 2819
Contact: Øystein Stubhaug, Clinic shief    +4761157002    oistein.stubhaug@sykehuset-innlandet.no   
Sponsors and Collaborators
University of Oslo
Investigators
Study Director: Mette Brekke, professor University of Oslo
  More Information

No publications provided

Responsible Party: Mette Brekke/Professor, University of Oslo
ClinicalTrials.gov Identifier: NCT01288846     History of Changes
Other Study ID Numbers: MBKF-03-UiO
Study First Received: February 2, 2011
Last Updated: February 3, 2011
Health Authority: Norway: Regional Ethics Commitee

Keywords provided by University of Oslo:
medication list
changes in medication
prescription medication

Additional relevant MeSH terms:
Cardiovascular Diseases
Respiration Disorders
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on August 25, 2014